Our mission
Upcoming events
Join Us
How to participate?
To join HELIOS and take part in its activities, visit the COST Action official webpage and apply to one or more Working Group of interest.
Recent news
Exploring AI Knowledge Gaps in Hematology- Abstract PB3837 Accepted at EHA 2025!
Exciting News: Abstract PB3837 Accepted at EHA 2025! We’re proud to announce that our abstract, PB3837, has been accepted for presentation at the European Hematology Association (EHA) 2025 Congress! This research
NHS Approves Revolutionary CRISPR Gene Therapy for Sickle Cell Disease
NHS Approves Revolutionary CRISPR Gene Therapy for Sickle Cell Disease In a landmark decision, the National Health Service (NHS) in England has approved the use of Casgevy, a groundbreaking CRISPR-based gene
Our first Short-Term Scientific Mission on standardizing annotation of structural hemoglobinopathies!
In March 2023, the first HELIOS-funded Short-Term Scientific Mission (STSM) was completed. The project was carried out by HELIOS member Maria Xenophontos from the Cyprus Institute of Neurology, in collaboration with
Action Details
CA22119 – Haemoglobinopathies in European Liaison of Medicine and Science (HELIOS)
Memorandum of Understanding – 029/23
CSO Approval date – 12/05/2023
Start date – 20/09/2023
End date – 19/09/2027
